Results
1 -
6 of
6
(Click
here to explore results)
- Pharmacological inhibition of fatty acid-binding protein 4 (FABP4) protects against renal ischemia-reperfusion injury. Min Shi, Rongshuang Huang, Fan Guo, Lingzhi Li, Yanhuan Feng, Zhengjie Wei, Li Zhou, Liang Ma, Ping Fu
, RSC Adv.
, 2018
, 8
, 15207
- Differential CRABP-II and FABP5 expression patterns and implications for medulloblastoma retinoic acid sensitivity. Song Zhang, Huan Liu, Hong Li, MoLi Wu, Yang Yu, FengZhi Li, XiaoXin Cheng
, RSC Adv.
, 2018
, 8
, 14048
- Therapeutic potential of a synthetic FABP4 inhibitor 8g on atherosclerosis in ApoE-deficient mice: the inhibition of lipid accumulation and inflammation. Heying Pei, Caifeng Xie, Yibin Liu, Mingfeng Shao, Jinying Chen, Dan Li, Liang Ma, Lijuan Chen
, RSC Adv.
, 2016
, 6
, 52518
- Discovery of Cobimetinib as a novel A-FABP inhibitor using machine learning and molecular docking-based virtual screening. Shilun Yang, Simeng Li, Junlei Chang
, RSC Adv.
, 2022
, 12
, 13500
- Delivery strategies in treatments of leukemia. Tianyuan Ci, Wentao Zhang, Yingyu Qiao, Huangjuan Li, Jing Zang, Hongjun Li, Nianping Feng, Zhen Gu
, Chem. Soc. Rev.
, 2022
, 51
, 2121
- Asiatic acid ameliorates obesity-related osteoarthritis by inhibiting myeloid differentiation protein-2. Xingfang Yu, Gang Zheng, Zhichao Hu, Shangkun Tang, Jianchen Xu, Ping Shang, Qian Tang, Haixiao Liu
, Food Funct.
, 2020
, 11
, 5513